some similar physicochemical and immunological properties, and the complete purification of follicle-stimulating hormone, for instance, has proved difficult. Many preparations which have appeared to be pure by one criterion have shown heterogeneity by another. Thus bioassay may reveal contaminating luteinizing hormone or specific radioimmunoassay may detect either luteinizing hormone or thyroid-stimulating hormone. Further, many of the apparently pure preparations described show a wide range of biological activities.
Loss of biological activity may occur during storage or during fractionation and concentration procedures. This may be the result of dissociation into subunits or of small chemical modifications. Thus activity decreases sharply with the loss of sialic acid residues, which occur at the terminal non-reducing ends of the carbohydrate chains (Butt, 1970; Kennedy & Butt, 1969) . These residues are labile and are readily cleaved at low pH. They carry considerable charge and forms of the hormone with variable amounts of sialic acid may be separated by isoelectric focusing. Luteinizing hormone is the most difficult of the glycoprotein hormones to remove from follicle-stimulating hormone : the separation is usually achieved by making use of their different isoelectric points in the techniques of electrophoresis or ion-exchange chromatography. Luteinizing hormone contains less sialic acid than follicle-stimulating hormone and the complete separation of these two may be made more difficult when some of the sialic acid residues have been removed from follicle-stimulating hormone.
One of the most successful methods has been described by Roos(1968) , whoworked on fresh frozen glands. They were extracted in a solution of phosphate buffer and purification proceeded by fractionation with (NH4)2S04, ion-exchange chromatography on DEAE-cellulose, gel filtration on Sephadex G-100, chromatography on hydroxyapatite and electrophoresis on polyacrylamide gel. Organic solvents were avoided throughout and concentration in between columns was by ultrafiltration. The final product was not dried because there was some evidence that as purification proceeds the stability of the hormone decreases, and there was danger that loss of biological activity may have resulted from such a process as freeze-drying. A rather similar method was described for acetone-dried glands by Peckham & Parlow (1969) . In several other methods the initial extraction from acetone-dried glands has been by use of mixtures of ammonium acetate and ethanol with the subsequent steps similar to those of Roos (1968) (Reichert et al., 1968; Saxena & Rathnam, 1971 ; Butt & Lynch, 1972) .
The method we have used consists of extraction of the acetone-dried glands in ammonium acetate-ethanol (3 :2, v/v; pH6.1) followed by chromatography on CMcellulose to separate the major portion of follicle-stimulating hormone from luteinizing hormone and thyroid stimulating hormone (Hartree, 1966) . The extract was precipitated from ethanol, redissolved in 1 mM-phosphate buffer at pH 7.5 and submitted to fractionation on calcium phosphate and DEAE-cellulose, and finally to gel filtration on Sephadex G-100 to separate subunit material. The chromatography on DEAE-cellulose is particularly important, since it is at this stage that most of theresidual luteinizinghormoneis removed. The process is best monitored by radioimmunoassays : most of the contaminating luteinizing hormone is eluted in 0.075~-ammonium acetate and the remainder with follicle-stimulating hormone on increasing the molarity to 0 . 1 2 5~. The latter is eluted from the Sephadex column in a position corresponding to a Stokes' radius of 3.1 nm. The biological activity averages about SO00 i.u./mg and the contamination due to luteinizing hormone is about 150 i.u./mg as measured by radioimmunoassay. Similar products have been obtaincd by ihe other methods listed, but the method of Roos(1968) appeared to give the highest estimate of biological activity at about 14000 i.u./mg with less than 0.1
The estimates of potency on the prcducts described vary considerably. A contributory factor may be tliat estimates of protein Concentration have usuaily been calcukted f r c z c.v.-absorp:ion or spcctrophotometric data. Potencies for dried preparations are not usually above 4000 i.u./mg and losses may occur during concentration by ultrafiltration, freeze-drying or precipiidiion from ethanol.
In spite of the detectable lutcinizing hormone in our product, it has proved to be suitable for thc deve!oprnent of spzcific radioimmunoassays. Antibodies were raised in rabbits by a multi-site-injection scheme similar to that described by Vaitukaitis et al. (1971) . A primary injection of not more than 1OOpg was administered intradermally at 30-40 sites on the backs of rabbits. Titres rose over a period of 10-12 weeks and then fell after a further 1&12 weeks. When the titre had fallen by 50% a secondary kijection of 20,ug was administered by the same route, after which very high titres were obtained within 2-3 weeks. The working concentrations in radioimmunoassay were of the order of 1 in 500000 and the antiscra had excellent affinities (Butt et al., 1974) . Binding of iodine-labellcd foliicle-stimulating hormone to the antibody was not inhibited by purified luteinizing hormone or by thyroid-stimulating hormone to any greater extent than the known contamination with follicle-stimulating hormone in these preparations.
A prerequisite to the further study of the chemistry of follicle-stimulating hormone and particularly the subunit structure, is the preparation of the most highly purified form of the dime;. Removal of the last traces of luteinizing hormone, although apparentiy unnecessary for radioimmunoassay, would be desirable. Since the ciassical techniques mentioned have proved not entirely satisfactory, it seemed that a more proniising approach may be by the use of highly specific antibodies. Successful applications in which the antibodies are linked to a solid support for affinity chromatography have been described for the porification of the urinary fo!licle-stimulating hormone by \.an Hell (1972) and for ovine 1uteinizi:ig hormone by Gospodarowicz (1972) . van He!l (1972) linked anti-(human chorionic gonadotrophin) xitiserum to Sepharose 4B and this adsorbed preferentially the luteinizing-hormone comporitnt of his preparation. Gospodarowicz (1972) , on the other hand, used high-titre anti-(Iuteinizing-hornone) antiserum to bind this hormone from crude extracts. The complex was then dissociated by eltition in 6~-guanidinz hydrochloride at pH 1.5 and a satisfactory product resulted.
The use of this eluting fluid can result in the dissociation of follicle-stimulating hormone into subunits and removal of sialic acid residues. Therefore we have used the simpler approach of removing the luteinizing hormone by means of a specific antiserum to this hormone. This antibody was attached to CH-Sepharose 4B by the carbodi-imide method and a column (20cm x 1 cm) was prepared for affinity chromatography. The preparation of follicle-stimiilating hormone was passed through in phosphate buffer and a radioimmunoassay for luteinizing hormone was carried out to check the eluate for the point where excess of lutcinizing hormone was eluted. In this way it has been possible to obtain follicle-stimulating hormone with n o luteinizing hormone contaminant detectable by radioimmunoassay.
The technique of affinity chromatography also promises to be of use in the preparation of subunits of follicle-stimulating hormone. Dissociation occurs in 8M-urea or 1 Mpropionic acid, but complete separation of the subunits is difficult. Vaitukaitis et af.
(1973) have used 1 M-propionicncid and passed the dissociated material through a column prepared from an antiserum to the common a subunit of the glycoprotein hormones which was raised in rabbits to a-human chorionic gonadotrophin. The column retained the a-follicle-stimulating hormone and any reassociated material, but pure /?-folliclestimulating hormone passed through.
luteinizing hormone by weight. Butt, W. R. (1970) Acta Endocrinol. (Copenhagen) Siippl. 142, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Butt, W. R. &Lynch, S. S. (1972) The application of radioimmunoassay techniques to the measurement of protein hormones in biological fluids has contributed greatly to progress in endocrinology. However, as knowledge of the physiology of hormonal regulation has increased it has become apparent that interpretation of immunoassay data may be difficult, since discrepancies can occur between the biological and immunological reactivity of protein hormones. It is now clear that the metabolism of these molecules in vivo may lead to polymorphism in the form of the circulating peptide and that different antisera may recognise the various forms to a greater or lesser extent (Franchimont et al., 1972) . In addition, the pituitary glycoprotein hormones present a number of unique problems in terms of immunological measurement, which derive primarily from their structural similarities. In this communication we shall outline the methodology that has been applied to the determination of protein hormones, and show how developments of the basic techniques can be applied to the specific problem of the measurement of the pituitary glycoprotein hormones in blood. The methodology employed in the conventional type of radioimmunoassay system has been reviewed extensively (Sonksen, 1974) . It involves the competitive binding of the hormone to be assayed and a radioactively labelled derivative of that hormone by an antiserum raised to that molecule or a partial sequence of it. At the end of the assay the ratio of bound to unbound radioligand is an inverse function of the amount of unlabelled hormone, present as standard or unknown, in the incubation. The same principle has been applied to the assay of several hormones with receptor proteins instead of antibodies. This method has the advantage that it recognizes only biologically active forms of the circulating molecules. Thus LH (luteinizing hormone) has been assayed by using preparations of ovarian (Lee & Ryan, 1972) or testicular tissue (Catt et al., 1971) and FSH (follicle-stimulating hormone) by using a rat testis tubular preparation (Reichert & Bhalla, 1974) . In addition to the problem of discriminating between LH and HCG (human chorionic gonadotrophin) activity, this type of system has the disadvantage of relatively low sensitivity, though one exception is the ACTH (adrenocorticotrophin) assay of Lefkowitz et al. (1970) . The problem has been further complicated by the difficulty of producing iodinated preparations of labelled hormones which retain their biological activity. It would seem that both the presence of radioiodine in a hormone molecule and exposure of the molecule to oxidizing agent during the iodination procedure are detrimental to hormonal binding.
